Nearly 90% of COVID-19 patients who qualified for but did not receive ECMO (extracorporeal membrane oxygenation) due to a shortage of devices during the pandemic died in the hospital.
An experimental gene therapy approach for treating sickle cell disease shows promise for eliminating painful crises that are associated with the condition, according to interim findings from a clinical trial.
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19.
Every two seconds someone in the U.S. needs blood. And according to the American Red Cross, a single donation can save up to three lives. On June 14, the National Heart, Lung, and Blood Institute (NHLBI) joins the World Health Organization (WHO) in observing World Blood Donor Day. Simone Glynn, M.D., M.P.H., chief of the Blood Epidemiology and...
Everyone responds to exercise differently. Now, researchers are reporting an advance toward a blood test that can help predict an individual’s best exercise choice for optimizing cardiorespiratory fitness.
Researchers are reporting new insights into a mysterious post-COVID illness called multisystem inflammatory syndrome in adults, or MIS-A.
The National Institutes of Health has halted a clinical trial evaluating the safety and effectiveness of COVID-19 convalescent plasma in treating emergency department patients who developed mild to moderate symptoms of COVID-19, the disease caused by the coronavirus SARS-CoV-2.